BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Cipher Pharmaceuticals Partner Moberg Pharma AB Provides Update on MOB-015 Phase 3 Study

  September 13, 2024

   · 

  6 min read
• Business

  IonQ Presents Winning Paper on Quantum Networking at IEEE Quantum Week

  September 13, 2024

   · 

  7 min read
• FDA

  FDA Approves Lilly’s EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis

  September 13, 2024

   · 

  14 min read
• Press Releases

  Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-to-severe Atopic Dermatitis in Adults

  September 13, 2024

   · 

  3 min read
• Press Releases

  Cytek Announces Resignation of Chief Operating Officer Chris Williams

  September 13, 2024

   · 

  5 min read
• Press Releases

  Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 12, 2024

  September 13, 2024

   · 

  2 min read
• Press Releases

  Aurinia Announces Board Restructuring

  September 13, 2024

   · 

  2 min read
• Press Releases

  Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

  September 13, 2024

   · 

  3 min read
• Press Releases

  Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 12, 2024

  September 13, 2024

   · 

  1 min read
• Press Releases

  XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

  September 13, 2024

   · 

  4 min read